RET and medullary thyroid gland carcinoma: In addition to the MTC follow-up examination, pheochromocytoma diagnosis by metanephrine and catecholamine determination is performed annually from the age of 11 years for high and highest risk RET mutations and from the age of 16 years for moderate risk RET mutations and other mutations, and MRI imaging is performed if necessary.